Risk Assessment

/Risk Assessment

New Tool Available for Calculating GIST Recurrence

The GIST Risk Calculator is based on research from Dr. Heikki Joensuu, Professor of Oncology at the University of Helsinki and the Research Director at the Helsinki Comprehensive Cancer Center, and his colleagues. The study drew [...]

By |2018-10-30T09:34:21-04:00September 15th, 2016|News, Risk Assessment|

Need for Extended Adjuvant Treatment to Prevent Recurrence in GIST May Be Underestimated

A recent study in JAMA Oncology found that patients who undergo primary GIST resection might not receive the optimal recommended duration of adjuvant therapy, which can impact their recurrence-free survival (RFS).The study was conducted by [...]

Conditional Disease-free Survival after GIST Resection Improves Over Time

In a recent study led by Danielle A Bischof, MD of Johns Hopkins and published in JAMA Surgery, the authors propose a new way of estimating disease-free survival for GIST patients – Conditional Disease-free Survival [...]

By |2019-04-08T09:46:50-04:00March 24th, 2015|News, Risk Assessment|

Recent Posts

Upcoming Events

  1. Kathy Sarmiento Medicare 101 Webcast

    LRG Webcast Series: Medicare 101

    September 9 @ 12:00 PM - 1:00 PM
  2. GDOL Ottawa logo

    GIST Day of Learning – Ottawa

    September 28 @ 9:00 AM - 4:30 PM